| Report ID | 278923 |
| Drug Identification Number | 02242904 |
| Brand name | MIDAZOLAM INJECTION, USP |
| Common or Proper name | Midazolam Injection, USP 1 mg/mL, 5 mL Vial |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | |
| Active Ingredient(s) | MIDAZOLAM |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 5 mL |
| ATC code | N05CD |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-04-01 |
| Actual start date | |
| Estimated end date | 2026-04-10 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-25 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a delay in production, we will be encountering a supply interruption on the following products. Please refer to the following table for details. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-25 | French | Compare |
| v1 | 2026-02-25 | English | Compare |
Showing 1 to 2 of 2